XBiotech Inc.
XBIT
$2.20
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.13M | -40.16M | -45.54M | -29.16M | -28.16M |
| Total Depreciation and Amortization | 1.44M | 1.58M | 1.69M | 1.75M | 1.76M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.11M | -1.45M | 294.00K | 6.03M | 4.46M |
| Change in Net Operating Assets | -112.00K | -2.14M | 3.64M | -2.12M | -3.15M |
| Cash from Operations | -40.70M | -42.17M | -39.92M | -23.51M | -25.09M |
| Capital Expenditure | -144.00K | -195.00K | -289.00K | -339.00K | -567.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.00K | 9.00K | -- | -- | -- |
| Cash from Investing | -139.00K | -186.00K | -289.00K | -339.00K | -567.00K |
| Total Debt Issued | -- | -- | -- | 250.00K | 250.00K |
| Total Debt Repaid | 0.00 | 0.00 | -10.25M | -10.25M | -10.25M |
| Issuance of Common Stock | -- | -- | -- | 33.00K | 97.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | -10.25M | -9.97M | -9.90M |
| Foreign Exchange rate Adjustments | -2.58M | 1.92M | 3.33M | -1.94M | -28.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.41M | -40.44M | -47.13M | -35.75M | -35.59M |